Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Stemcell United Ltd. ( (AU:BP8) ).
Stemcell United Ltd. has announced its first shipment of seaweed under a Sales Cooperation Agreement with PT Kebula Raya Bestari to South Korean food ingredient manufacturer MSC, Ltd. This initial contract involves supplying 60 metric tonnes of Indonesian seaweed biomass valued at USD 62,400. The shipment marks a significant operational milestone for the company, highlighting its strategic partnership with Kebula, which manages logistics and supply arrangements. The agreement includes a profit-sharing mechanism between BP8 and Kebula and is expected to enhance BP8’s international market presence by connecting Indonesian seaweed supply with global customers.
More about Stemcell United Ltd.
Stemcell United Ltd. operates in the biotechnology industry, focusing on the cultivation and supply of seaweed products. The company is involved in the production and distribution of seaweed biomass, which is used as a raw material for various applications, including food ingredients.
Current Market Cap: A$2.1M
See more data about BP8 stock on TipRanks’ Stock Analysis page.